Effects of lithium on platelet membrane phosphoinositides in bipolar disorder patients: A pilot study

Psychopharmacology

Volumn 149, Issue 1, 2000, Pages 12-16

  Soares, Jair C ^a   Mallinger, Alan G ^a,b   Dippold, Christine S ^a   Forster Wells, Kelly ^a   Frank, Ellen ^a,b   Kupfer, David J ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Lithium; Mechanism of action; Phosphoinositides; Platelet; Signal transduction

Indexed keywords

LITHIUM; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 4 PHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE MEMBRANE;

EID: 0034069859     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002139900341     Document Type: Article

References (39)

1. Agam G, Livne A (1989) Inositol-1-phosphatase of human erythrocytes is inhibited by therapeutic lithium concentrations. Psychiatry Res 27:217-224
2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Press, Washington, D.C.
3. Atack JR (1995) Inositol monophosphatase inhibitors: a novel treatment for bipolar disorder? Biol Psychiatry 37:761-763
4. Baraban JM, Worley PF, Snyder SH (1989) Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium. Am J Psychiatry 146:1251-1260
5. Belmaker RH, Bersudsky Y, Benjamin J, Agam G, Levine J, Kofman O (1995) Manipulation of inositol-linked second messenger systems as a therapeutic strategy in psychiatry. Adv Biochem Psychopharmacol 49:67-84
6. Belmaker RH, Bersudsky Y, Agam G, Levine J, Kofman O (1996) How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory. Annu Rev Med 47:47-56
7. Berridge MJ, Downes CP, Hanley MR (1989) Neural and developmental actions of lithium: a unifying hypothesis. Cell 59:411-419
8. Brown AS, Mallinger AG, Renbaum LC (1993) Elevated platelet membrane phosphatidylinositol-4,5-bisphosphate in bipolar mania. Am J Psychiatry 150:1252-1254
9. Drummond AH (1988) Lithium affects G-protein receptor coupling. Nature 331:388
10. Dubovsky SL, Murphy J, Christiano J, Lee C (1992) The calcium second messenger system in bipolar disorders: data supporting new research directions. J Neuropsychiatr Clin Neurosci 4:3-14
11. Ebstein RP, Lerer B, Bennett ER, Dayek DB, Newman ME, Shapira B, Kindler S (1986) Second messenger function in lymphocytes and platelets: a comparison of peripheral and central mechanisms. Clin Neuropharmacol 9:350-352
12. Eckert A, Gann H, Riemann D, Aldenhoff J, Muller WE (1994) Platelet and lymphocyte free intracellular calcium in affective disorders. Eur Arch Psychiatr Clin Neurosci 243:235-239
13. 2+ response in neutrophils from patients under chronic lithium therapy. Eur Arch Psychiatr Clin Neurosci 243:240-243
14. Friedman E, Hoau-Yan-Wang, Levinson D, Connell TA, Singh H (1993) Altered platelet protein kinase C activity in bipolar affective disorder, manic episode. Biol Psychiatry 33:520-525
15. Gershon S, Soares JC (1997) Commentary - current therapeutic profile of lithium. Arch Gen Psychiatry 54:16-20
16. Imahori Y, Fujii R, Ueda S, Matsumoto K, Wakita K, Ido T, Nariai T, Nakahashi H (1992) Membrane trapping of carbon-11-labeled 1,2-diacylglycerols as a basic concept for assessing phosphatidylinositol turnover in neurotransmission process. J Nucl Med 33:413-422
17. Imahori Y, Fujii R, Ueda S, Ohmori Y, Wakita K, Matsumoto K (1993) Phosphoinositide turnover imaging linked to muscarinic cholinergic receptor in the central nervous system by positron emission tomography. J Nucl Med 34:1543-1551
18. Jope RS, Song L, Li PP, Young LT, Kish SJ, Pacheco MA, Warsh JJ (1996) The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. J Neurochem 66:2402-2409
19. Kusumi I, Koyama T, Yamashita I (1992) Thrombin-induced platelet calcium mobilization is enhanced in bipolar disorders. Biol Psychiatry 32:731-734
20. Lachman HM, Papolos DF (1989) Abnormal signal transduction: a hypothetical model for bipolar affective disorder. Life Sci 45:1413-1426
21. Lenox RH, Watson DG (1994) Lithium and the brain: a psychopharmacological strategy to a molecular basis for manic depressive illness. Clin Chem 40:309-314
22. Mallinger AG, Yao JK, Brown AS, Dippold CS (1993) Analysis of complex mixtures of phospholipid classes from cell membranes using two-dimensional thin-layer chromatography and scanning laser densitometry. J Chromatogr 614:67-75
23. Manji HK, Chen G, Shimon H, Hsiao JK, Potter WZ, Belmaker RH (1995a) Guanine nucleotide-binding proteins in bipolar affective disorder. Effects of long-term lithium treatment. Arch Gen Psychiatry 52:135-44
24. Manji HK, Potter WZ, Lenox RH (1995b) Signal transduction pathways. Molecular targets for lithium's actions. Arch Gen Psychiatry 52:531-543
25. Molchan SE, Atack JR, Sunderland T (1994) Decreased CSF inositol monophosphatase activity after lithium treatment. Psychiatry Res 53:103-105
26. Moscovich DG, Belmaker RH, Agam G, Livne A (1990) Inositol-1-phosphatase in red blood cells of manic-depressive patients before and during treatment with lithium. Biol Psychiatry 27:552-555
27. Pletscher A (1986) Blood platelets as neuronal models: use and limitations. Clin Neuropharmacol 9:344-346
28. Schou M (1997) Forty years of lithium treatment. Arch Gen Psychiatry 54:9-13
29. Snyder SH (1992) Second messengers and affective illness - focus on the phosphoinositide cycle. Pharmacopsychiatry 25:25-28
30. Soares JC, Gershon S (1998) The lithium ion: a foundation for psychopharmacological specificity. Neuropsychopharmacology 19:167-182
31. Soares JC, Mallinger AG (1996) Abnormal phosphatidylinositol (PI)-signalling in bipolar disorder. Biol Psychiatry 39:461-462
32. Soares JS, Mallinger AG (1997) Intracellular phosphatidylinositol pathway abnormalities in bipolar disorder patients. Psychopharmacol Bull 33:685-691
33. Soares JC, Krishnan KRR, Keshavan MS (1996) Nuclear magnetic resonance spectroscopy - new insights into the pathophysiology of mood disorders. Depression 4:14-30
34. Soares JC, Dippold CS, Mallinger AG (1997) Platelet membrane phosphatidylinositol-4,5-bisphosphate alterations in bipolar disorder - evidence from a single case study. Psychiatry Res 69:197-202
35. Soares JC, Dippold BS, Wells KF, Houck P, Mallinger AG (1999a) Reproducibility of in vivo measures of platelet membrane phospholipids in human subjects. Psychiatry Res 86:107-112
36. Soares JC, Dippold CS, Mallinger AG, Frank E, Kupfer DJ (1999b) Platelet membrane phospholipids in euthymic bipolar disorder patients: are they affected by lithium treatment? Biol Psychiatry 45:453-457
37. Vadnal R, Parthasarathy R (1995) Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate. Neuropsychopharmacology 12:277-285
38. Wachtel H (1989) Dysbalance of neuronal second messenger function in the aetiology of affective disorders: a pathophysiological concept hypothesizing defects beyond first messenger receptors. J Neural Transm 75:21-29
39. Young LT, Li PP, Kish SJ, Siu KP, Warsh JJ (1991) Postmortem cerebral cortex Gs alpha-subunit levels are elevated in bipolar affective disorder. Brain Res 553:323-326